LG 2000 Guide De L'utilisateur page 80

2. What is the FDA's role concerning the safety
of wireless phones?
Under the law, the FDA does not review the safety
of radiation-emitting consumer products such as
wireless phones before they can be sold, as it does
with new drugs or medical devices. However, the
agency has authority to take action if wireless
phones are shown to emit radiofrequency energy
(RF) at a level that is hazardous to the user. In such
a case, the FDA could require the manufacturers of
wireless phones to notify users of the health hazard
and to repair, replace or recall the phones so that
the hazard no longer exists.
Although the existing scientific data do not justify
FDA regulatory actions, the FDA has urged the
wireless phone industry to take a number of steps,
including the following:
]
Support needed research into possible biological
effects of RF of the type emitted by wireless phones;
]
Design wireless phones in a way that minimizes
any RF exposure to the user that is not necessary
for device function; and
]
Cooperate in providing users of wireless phones
with the best possible information on possible
effects of wireless phone use on human health.
The FDA belongs to an interagency working group
of the federal agencies that have responsibility for
different aspects of RF safety to ensure coordinated
efforts at the federal level. The following agencies
belong to this working group:
o National Institute for Occupational Safety and
Health
o Environmental Protection Agency
o Occupational Safety and Health Administration
o National Telecommunications and Information
Administration
The National Institutes of Health participates in
some interagency working group activities as well.
The FDA shares regulatory responsibilities for
wireless phones with the Federal Communications
Commission (FCC). All phones that are sold in the
United States must comply with FCC safety
guidelines that limit RF exposure. The FCC relies on
the FDA and other health agencies for safety
questions about wireless phones.
Safety Guidelines
79